Corbus Pharmaceuticals Holdings, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
CRBP on Nasdaq
Location
500 River Ridge Drive, Norwood, MA

Insiders trading volume in the past year

Corbus Pharmaceuticals Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $52.8M Sep 20, 2024
Rachael Brake Chief Scientific Officer $6.96M Feb 13, 2023
Craig Millian Chief Operating Officer $4.78M Feb 13, 2023
Yuval Cohen Chief Executive Officer, Director $2.37M -$534K -18.4% Oct 24, 2025
Sean Moran Chief Financial Officer $1.25M -$245K -16.4% Oct 24, 2025
Dominic Smethurst Chief Medical Officer $480K -$43.3K -8.28% Mar 6, 2025
Alan Holmer Director $254K May 30, 2025
Ian Hodgson Chief Operating Officer $168K Mar 13, 2025
Avery Catlin Director $144K May 30, 2024
Rachelle Suzanne Jacques Director $140K May 30, 2025
Yong Ben Director $140K May 30, 2025
Anne Altmeyer Director $127K -$31.8K -20% Oct 20, 2025
John Jenkins Director $121K -$20.5K -14.5% May 30, 2025
Peter Salzmann Director $97.3K May 30, 2024
Winston Kung Director $77.4K May 30, 2025

Recent Insider Transactions by Companies or Individuals for Corbus Pharmaceuticals Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.